Lactoferrin inhibits human papillomavirus binding and uptake in vitro

Antiviral Research

Volumn 64, Issue 1, 2004, Pages 63-68

  Drobni, Peter ^a   Näslund, Jonas ^a   Evander, Magnus ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Antiviral activity; Heparan sulfate; Human papillomavirus; Lactoferrin

Indexed keywords

CELL RECEPTOR; HEPARAN SULFATE; LACTOFERRIN;

ADENOVIRUS; ANALYTIC METHOD; ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL LABELING; CELL SURFACE; CONDYLOMA; CONTROLLED STUDY; DEFENSE MECHANISM; DOSE RESPONSE; FLUORESCENCE; HERPES VIRUS; IN VITRO STUDY; NONHUMAN; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FAMILY; ROTAVIRUS; UTERINE CERVIX CANCER; VIRUS INFECTION; VIRUS TYPING; WART VIRUS; WESTERN BLOTTING;

ADSORPTION; ANIMALS; ANTIVIRAL AGENTS; CATTLE; CELL LINE; HUMANS; LACTOFERRIN; PAPILLOMAVIRIDAE; RECEPTORS, VIRUS;

ADENOVIRIDAE; BOVINAE; HERPESVIRIDAE; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; PAPILLOMAVIRUS; POLIOVIRUS; ROTAVIRUS;

EID: 4644281454     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2004.05.005     Document Type: Article

References (52)

1. J.H. Andersen, S.A. Osbakk, L.H. Vorland, T. Traavik, and T.J. Gutteberg Lactoferrin and cyclic lactoferricin inhibit the entry of human cytomegalovirus into human fibroblasts Antiviral Res. 51 2001 141 149
2. J.H. Andersen, H. Jenssen, and T.J. Gutteberg Lactoferrin and lactoferricin inhibit Herpes simplex 1 and 2 infection and exhibit synergy when combined with acyclovir Antiviral Res. 58 2003 209 215
3. W. Bellamy, H. Wakabayashi, M. Takase, K. Kawase, S. Shimamura, and M. Tomita Killing of Candida albicans by lactoferricin B, a potent antimicrobial peptide derived from the N-terminal region of bovine lactoferrin Med. Microbiol. Immunol. (Berl) 182 1993 97 105
4. N.D. Christensen, N.M. Cladel, and C.A. Reed Postattachment neutralization of papillomaviruses by monoclonal and polyclonal antibodies Virology 207 1995 136 142
5. U. Claesson, A. Lassus, H. Happonen, L. Hogstrom, and A. Siboulet Topical treatment of venereal warts: a comparative open study of podophyllotoxin cream versus solution Int. J. STD AIDS 7 1996 429 434
6. M.S. Cohen, B.E. Britigan, M. French, and K. Bean Preliminary observations on lactoferrin secretion in human vaginal mucus: variation during the menstrual cycle, evidence of hormonal regulation, and implications for infection with Neisseria gonorrhoeae Am. J. Obstet. Gynecol. 157 1987 1122 1125
7. A.L. Combita, A. Touze, L. Bousarghin, P.Y. Sizaret, N. Munoz, and P. Coursaget Gene transfer using human papillomavirus pseudovirions varies according to virus genotype and requires cell surface heparan sulfate FEMS Microbiol. Lett. 204 2001 183 188
8. P.M. Day, D.R. Lowy, and J.T. Schiller Papillomaviruses infect cells via a clathrin-dependent pathway Virology 307 2003 1 11
9. A.M. Di Biase, A. Pietrantoni, A. Tinari, R. Siciliano, P. Valenti, G. Antonini, L. Seganti, and F. Superti Heparin-interacting sites of bovine lactoferrin are involved in anti-adenovirus activity J. Med. Virol. 69 2003 495 502
10. P. Drobni, N. Mistry, N. McMillan, and M. Evander Carboxy-fluorescein diacetate, succinimidyl ester labeled papillomavirus virus-like particles fluoresce after internalization and interact with heparan sulfate for binding and entry Virology 310 2003 163 172
11. L. Edwards, A. Ferenczy, L. Eron, D. Baker, M.L. Owens, T.L. Fox, A.J. Hougham, K.A. Schmitt HPV Study Group. Human PapillomaVirus Self-administered topical 5% imiquimod cream for external anogenital warts. Arch. Dermatol. 134 1998 25 30
12. M. Evander, I.H. Frazer, E. Payne, Y.M. Qi, K. Hengst, and N.A. McMillan Identification of the alpha6 integrin as a candidate receptor for papillomaviruses J. Virol. 71 1997 2449 2456
13. J. Farley, D. Loup, M. Nelson, A. Mitchell, G. Esplund, C. Macri, C. Harrison, and K. Gray Neoplastic transformation of the endocervix associated with downregulation of lactoferrin expression Mol. Carcinog. 20 1997 240 250
14. T. Giroglou, L. Florin, F. Schafer, R.E. Streeck, and M. Sapp Human papillomavirus infection requires cell surface heparan sulfate J. Virol. 75 2001 1565 1570
15. M.E. Hagensee, N. Yaegashi, and D.A. Galloway Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins J. Virol. 67 1993 315 322
16. N.E. Hansen, J. Malmquist, and J. Thorell Plasma myeloperoxidase and lactoferrin measured by radioimmunoassay: relations to neutrophil kinetics Acta Med. Scand. 198 1975 437 443
17. K. Hara, M. Ikeda, S. Saito, S. Matsumoto, K. Numata, N. Kato, K. Tanaka, and H. Sekihara Lactoferrin inhibits hepatitis B virus infection in cultured human hepatocytes Hepatol. Res. 24 2002 228
18. J.G. Joyce, J.S. Tung, C.T. Przysiecki, J.C. Cook, E.D. Lehman, J.A. Sands, K.U. Jansen, and P.M. Keller The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes J. Biol. Chem. 274 1999 5810 5822
19. R. Kirnbauer, F. Booy, N. Cheng, D.R. Lowy, and J.T. Schiller Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic Proc. Natl. Acad. Sci. U.S.A. 89 1992 12180 12184
20. T.Y. Lin, C. Chu, and C.H. Chiu Lactoferrin inhibits enterovirus 71 infection of human embryonal rhabdomyosarcoma cells in vitro J. Infect. Dis. 186 2002 1161 1164
21. M. Marchetti, C. Longhi, M.P. Conte, S. Pisani, P. Valenti, and L. Seganti Lactoferrin inhibits herpes simplex virus type 1 adsorption to Vero cells Antiviral Res. 29 1996 221 231
22. M. Marchetti, F. Superti, M.G. Ammendolia, P. Rossi, P. Valenti, and L. Seganti Inhibition of poliovirus type 1 infection by iron-, manganese- and zinc-saturated lactoferrin Med. Microbiol. Immunol. (Berl) 187 1999 199 204
23. K.B. McCann, A. Lee, J. Wan, H. Roginski, and M.J. Coventry The effect of bovine lactoferrin and lactoferricin B on the ability of feline calicivirus (a norovirus surrogate) and poliovirus to infect cell cultures. J. Appl. Microbiol. 95 2003 1026 1033
24. M.E. McLaughlin-Drubin, S. Wilson, B. Mullikin, J. Suzich, and C. Meyers Human papillomavirus type 45 propagation, infection, and neutralization Virology 312 2003 1 7
25. M.H. Metz-Boutigue, J. Jolles, J. Mazurier, F. Schoentgen, D. Legrand, G. Spik, J. Montreuil, and P. Jolles Human lactotransferrin: amino acid sequence and structural comparisons with other transferrins Eur. J. Biochem. 145 1984 659 676
26. C. Meyers, J.L. Bromberg-White, J. Zhang, M.E. Kaupas, J.T. Bryan, R.S. Lowe, and K.U. Jansen Infectious virions produced from a human papillomavirus type 18/16 genomic DNA chimera J. Virol. 76 2002 4723 4733
27. M. Muller, L. Gissmann, R.J. Cristiano, X.Y. Sun, I.H. Frazer, A.B. Jenson, A. Alonso, H. Zentgraf, and J. Zhou Papillomavirus capsid binding and uptake by cells from different tissues and species J. Virol. 69 1995 948 954
28. M.E. Murphy, H. Kariwa, T. Mizutani, H. Tanabe, K. Yoshimatsu, J. Arikawa, and I. Takashima Characterization of in vitro and in vivo antiviral activity of lactoferrin and ribavirin upon hantavirus J. Vet. Med. Sci. 63 2001 637 645
29. M.A. Ozbun Human papillomavirus type 31b infection of human keratinocytes and the onset of early transcription J. Virol. 76 2002 11291 11300
30. M.A. Ozbun Infectious human papillomavirus type 31b: purification and infection of an immortalized human keratinocyte cell line J. Gen. Virol. 83 2002 2753 2763
31. D.S. Park, L.A. Selvey, S.R. Kelsall, and I.H. Frazer Human papillomavirus type 16 E6, E7 and L1 and type 18 E7 proteins produced by recombinant baculoviruses. J. Virol. Methods 45 1993 303 318
32. C.S. Petersen, T. Agner, V. Ottevanger, J. Larsen, and L. Ravnborg A single-blind study of podophyllotoxin cream 0.5% and podophyllotoxin solution 0.5% in male patients with genital warts Genitourin Med. 71 1995 391 392
33. A. Pierce, D. Colavizza, M. Benaissa, P. Maes, A. Tartar, J. Montreuil, and G. Spik Molecular cloning and sequence analysis of bovine lactotransferrin Eur. J. Biochem. 196 1991 177 184
34. A. Pietrantoni, A.M. Di Biase, A. Tinari, M. Marchetti, P. Valenti, L. Seganti, and F. Superti Bovine lactoferrin inhibits adenovirus infection by interacting with viral structural polypeptides Antimicrob. Agents Chemother. 47 2003 2688 2691
35. Y.M. Qi, S.W. Peng, K. Hengst, M. Evander, D.S. Park, J. Zhou, and I.H. Frazer Epithelial cells display separate receptors for papillomavirus VLPs and for soluble L1 capsid protein Virology 216 1996 35 45
36. R.B. Roden, R. Kirnbauer, A.B. Jenson, D.R. Lowy, and J.T. Schiller Interaction of papillomaviruses with the cell surface J. Virol. 68 1994 7260 7266
37. R.C. Rose, W. Bonnez, R.C. Reichman, and R.L. Garcea Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles J. Virol. 67 1993 1936 1944
38. H.C. Selinka, T. Giroglou, T. Nowak, N.D. Christensen, and M. Sapp Further evidence that papillomavirus capsids exist in two distinct conformations J. Virol. 77 2003 12961 12967
39. S. Shafti-Keramat, A. Handisurya, E. Kriehuber, G. Meneguzzi, K. Slupetzky, and R. Kirnbauer Different heparan sulfate proteoglycans serve as cellular receptors for human papillomaviruses J. Virol. 77 2003 13125 13135
40. G. Spik, D. Legrand, B. Leveugle, J. Mazurier, T. Mikogami, J. Montreuil, A. Pierce, and E. Rochard Characterization of two kinds of lactotransferrin (lactoferrin) receptors on different target cells Adv. Exp. Med. Biol. 357 1994 13 19
41. A. Strand, R.M. Brinkeborn, and A. Siboulet Topical treatment of genital warts in men, an open study of podophyllotoxin cream compared with solution Genitourin Med. 71 1995 387 390
42. F. Superti, M.G. Ammendolia, P. Valenti, and L. Seganti Antirotaviral activity of milk proteins: lactoferrin prevents rotavirus infection in the enterocyte-like cell line HT-29 Med. Microbiol. Immunol. (Berl) 186 1997 83 91
43. P.J. Swart, M.E. Kuipers, C. Smit, Pauwels F R, M.P deBethune, E J de Clercq, D.K Meijer, and J.G Huisman Antiviral effects of milk proteins: acylation results in polyanionic compounds with potent activity against human immunodeficiency virus types 1 and 2 in vitro AIDS Res. Hum. Retroviruses 12 1996 769 775
44. B.W. van der Strate, L. Beljaars, G. Molema, M.C. Harmsen, and D.K. Meijer Antiviral activities of lactoferrin Antiviral. Res. 52 2001 225 239
45. C. Volpers, F. Unckell, P. Schirmacher, R.E. Streeck, and M. Sapp Binding and internalization of human papillomavirus type 33 virus-like particles by eukaryotic cells J. Virol. 69 1995 3258 3264
46. L.H. Vorland, H. Ulvatne, J. Andersen, H.H. Haukland, O. Rekdal, J.S. Svendsen, and T.J. Gutteberg Antibacterial effects of lactoferricin B Scand. J. Infect. Dis. 31 1999 179 184
47. G. von Krogh, C.J. Lacey, G. Gross, R. Barrasso, and A. Schneider European course on HPV associated pathology: guidelines for primary care physicians for the diagnosis and management of anogenital warts Sex Transm. Infect. 76 2000 162 168
48. H.F. Wu, D.M. Monroe, and F.C. Church Characterization of the glycosaminoglycan-binding region of lactoferrin Arch. Biochem. Biophys. 317 1995 85 92
49. R. Xiao, and W.S. Kisaalita Iron acquisition from transferrin and lactoferrin by Pseudomonas aeruginosa pyoverdin Microbiology 143 Pt 7 1997 2509 2515
50. M. Yi, S. Kaneko, D.Y. Yu, and S. Murakami Hepatitis C virus envelope proteins bind lactoferrin J. Virol. 71 1997 5997 6002
51. C.S. Yoon, K.D. Kim, S.N. Park, and S.W. Cheong alpha(6) Integrin is the main receptor of human papillomavirus type 16 VLP Biochem. Biophys. Res. Commun. 283 2001 668 673
52. H. zur Hausen Papillomaviruses and cancer: from basic studies to clinical application Nat. Rev. Cancer 2 2002 342 350